Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.12.23 | Incyte and Syndax Pharmaceuticals: Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease | 683 | Business Wire | Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first six months of treatment
Data are featured... ► Artikel lesen | |
10.12.23 | Innate Pharma SA: Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023 | 682 | Business Wire | Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will... ► Artikel lesen | |
10.12.23 | Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation | 476 | Business Wire | Today, H.E. Alexander De Croo, Prime Minister of Belgium, witnessed the signing of a Memorandum of Understanding on Energy Transition Cooperation between three Belgian and three Houston-based partners... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 227 |
BAYER | 203 |
NEL | 192 |
NVIDIA | 164 |
TUI | 157 |
SIEMENS ENERGY | 154 |
RHEINMETALL | 139 |
PLUG POWER | 133 |
MERCEDES-BENZ | 128 |
BYD | 123 |
NOVAVAX | 116 |
TESLA | 105 |
DEUTSCHE BANK | 103 |
PALANTIR TECHNOLOGIES | 102 |
RWE | 97 |
DEUTSCHE LUFTHANSA | 88 |
BASF | 87 |
ALLIANZ | 83 |
VOLKSWAGEN | 82 |
THYSSENKRUPP | 70 |
COMMERZBANK | 69 |
AMAZON | 63 |
INFINEON | 62 |
E.ON | 59 |
NORDEX | 59 |